Investigate Novel Epigenetic Silencing Mechanisms in Mouse ESCs
Investigate Novel Epigenetic Silencing Mechanisms in Mouse ESCs
批准号:
8860450
负责人:
zhuo Andrew Xiao
金额:
$41.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-13 至 2020-02-29
关键词:
AgingBindingBiochemicalBiochemistryBiological ProcessCellsClustered Regularly Interspaced Short Palindromic RepeatsComplexDNADataDevelopmentEmbryoEpigenetic ProcessFamilyGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionGenomeGoalsGuide RNAIn VitroInvestigationKnowledgeMaintenanceMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMediatingMethodologyMolecularMusN-terminalOutcomePlayPositioning AttributePublicationsRecruitment ActivityRegulatory PathwayReportingRepressionRetrotransposonRoleSiteStagingStem cellsSystemTranscriptional RegulationWorkbasedevelopmental diseaseembryo cellembryo tissueembryonic stem cellepigenomicsexperiencegenome-widegenome-wide analysishuman diseasein vivoinnovationinterestinterstitialnovelnovel strategiespluripotencypromoterprotein complexpublic health relevanceresearch studystem cell biologystem cell fatetelomeretooltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of our proposed study is to identify novel epigenetic mechanisms for regulating important biological process. Investigating epigenetic silencing complexes in controlling mouse embryonic stem cells (ESCs) fate provides an ideal platform for our investigation. Our recent work has identified the novel role of Rif1 gene
as an epigenetic silencing factor for 2-Cell embryo genes and trophectoderm genes ESCs. This repression is critical for cell fate maintenance in ESCs. Previous studies showed that a rare family of endogenous retrotransposon (<0.05%), MERV-L, serves as promoters for 2-Cell embryo gene expression but little is known about the regulatory mechanisms. In addition, trophectoderm genes need to be silenced in order to maintain the commitment of ESCs to embryonic tissues but the molecular underpinning remains elusive. Besides these intriguing issues, a longstanding interest in the field is to develop simple and reliable approaches to study epigenetic factors in a locus-specific manner. Our most recent preliminary studies have identified a novel epigenetic silencing complex in ESCs, Rif1 epigenetic silencing complex (RESC). Our studies also led to unexpected mechanisms for RESC-mediated silencing. First, we demonstrated that interstitial telomeric sequences (telomere-like sequences located in intrachromosomal sites), which are strongly enriched at flanking regions of MERV-L, play a critical role in RESC-mediated silencing of 2-Cell embryo genes. Second, Rif1's interaction with pluripotency transcription factors is critical for repressing trophectoderm genes, which don't have MERV-L as promoters. Based on these findings, we hypothesize that RESC utilizes distinct mechanisms for targeting different genes. Furthermore, we have been developing new approaches that are based on the modified CRISPR/Cas9 systems to study epigenetic silencing in a locus specific manner. These approaches can tether epigenetic factors to target genes (CRISPR tethering) or pull out factors from specific loci by biochemistry means (CRISPR pull-out), respectively. In this proposal, we will fully investigate the mechanisms underlying RESC- mediated silencing and fully develop CRISPR-based approaches for studying epigenetic silencing. The significance and innovation of this study lie in several fronts. First, the outcomes
will reveal novel mechanisms for recruiting epigenetic factors as well as cell fate decisions in ESC. Second, this work will add an interesting twist to the classic position variegation effects (o telomere position effect), i.e. the role of interstitial telomeric sequences in the epigenetic silencing of early embryonic genes, which has never been reported in mammalian cells. Third, the new methodologies under development will provide useful tools for studying transcriptional regulation and epigenetics in a locus specific manner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel epigenetic mechanism in early embryogenesis
-
批准号:10799233
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2020
-
负责人:zhuo Andrew Xiao
-
依托单位:
A novel epigenetic mechanism in early embryogenesis
-
批准号:10369001
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2020
-
负责人:zhuo Andrew Xiao
-
依托单位:
A novel epigenetic mechanism in early embryogenesis
-
批准号:10584485
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2020
-
负责人:zhuo Andrew Xiao
-
依托单位:
Investigate Novel Epigenetic Silencing Mechanisms in Mouse ESCs
-
批准号:9034611
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2015
-
负责人:zhuo Andrew Xiao
-
依托单位:
Investigate Novel Epigenetic Silencing Mechanisms in Mouse ESCs
-
批准号:9221346
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2015
-
负责人:zhuo Andrew Xiao
-
依托单位:
A novel enzymatic activity of WSTF and its role in tumorigenesis
-
批准号:8122501
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:zhuo Andrew Xiao
-
依托单位:
A novel enzymatic activity of WSTF and its role in tumorigenesis
-
批准号:8132579
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2009
-
负责人:zhuo Andrew Xiao
-
依托单位:
A novel enzymatic activity of WSTF and its role in tumorigenesis
-
批准号:7662654
-
项目类别:
-
资助金额:$5.36万
-
财政年份:2009
-
负责人:zhuo Andrew Xiao
-
依托单位:
A novel enzymatic activity of WSTF and its role in tumorigenesis
-
批准号:8036443
-
项目类别:
-
资助金额:$7.2万
-
财政年份:2009
-
负责人:zhuo Andrew Xiao
-
依托单位:
A novel enzymatic activity of WSTF and its role in tumorigenesis
-
批准号:8279098
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2009
-
负责人:zhuo Andrew Xiao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: